Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Carroll

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Blood|October 26, 2016
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemiaSarah K Tasian, David T Teachey, Yong Li, et al.
Nucleic Acids Research|December 6, 2018
Aberrant splicing in B-cell acute lymphoblastic leukemiaKathryn L Black, Ammar S Naqvi, Mukta Asnani, et al.
Nucleic Acids Research|October 26, 2018
Aberrant splicing in B-cell acute lymphoblastic leukemiaKathryn L Black, Ammar S Naqvi, Mukta Asnani, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphateRoberta Buono, Dennis Juarez, Madhuri Paul, et al.
Cancer Letters|September 3, 2025
TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemiaAurélien Pottier, Sujung Park, Yejin Lee, et al.
Investigational New Drugs|April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibitionMargaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient miceZainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Cancer Discovery|January 20, 2022
Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid LeukemiaMarta Galán-Díez, Florence Borot, Abdullah Mahmood Ali, et al.
Cancer Biology & Therapy|January 6, 2007
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexaroteneDonald E Tsai, Selina M Luger, Allison Kemner, et al.
The Journal of Clinical Investigation|May 7, 2024
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Blood|October 26, 2016
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemiaSarah K Tasian, David T Teachey, Yong Li, et al.
Nucleic Acids Research|December 6, 2018
Aberrant splicing in B-cell acute lymphoblastic leukemiaKathryn L Black, Ammar S Naqvi, Mukta Asnani, et al.
Nucleic Acids Research|October 26, 2018
Aberrant splicing in B-cell acute lymphoblastic leukemiaKathryn L Black, Ammar S Naqvi, Mukta Asnani, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphateRoberta Buono, Dennis Juarez, Madhuri Paul, et al.
Cancer Letters|September 3, 2025
TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemiaAurélien Pottier, Sujung Park, Yejin Lee, et al.
Investigational New Drugs|April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibitionMargaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient miceZainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Cancer Discovery|January 20, 2022
Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid LeukemiaMarta Galán-Díez, Florence Borot, Abdullah Mahmood Ali, et al.
Cancer Biology & Therapy|January 6, 2007
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexaroteneDonald E Tsai, Selina M Luger, Allison Kemner, et al.
The Journal of Clinical Investigation|May 7, 2024
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignanciesXiaolei Liu, Sudhish A Devadiga, Robert F Stanley, et al.
Pageof 13